The impact of medication therapy management in older oncology patients

Supportive Care in Cancer

Volumn 21, Issue 5, 2013, Pages 1287-1293

  Yeoh, Ting Ting ^a   Si, Phebe ^a   Chew, Lita ^a,b  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Drug related problems; Elderly cancer patients; Medication therapy management

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT;

ADVERSE DRUG REACTION; AGED; ARTICLE; CANCER CHEMOTHERAPY; DRUG INTERACTION; DRUG RELATED PROBLEM; FEMALE; GERIATRIC CARE; HEALTH CARE CONCEPTS; HEALTH SERVICE; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; TREATMENT REFUSAL; UNSPECIFIED SIDE EFFECT;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MEDICATION THERAPY MANAGEMENT; NEOPLASMS; PATIENT SATISFACTION; PHARMACEUTICAL SERVICES; PHARMACISTS; PROFESSIONAL ROLE; PROSPECTIVE STUDIES;

EID: 84879692524     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1661-y     Document Type: Article

References (38)

1. American Pharmacist Association (APhA). (2004) Medication therapy management services definition and program criteria Jul 2004. Available at http://www.aacp.org/resources/historicaldocuments/Documents/ MTMServicesDefinitionandProgramCriteria04.pdf. Assessed 05 October 2011
2. American College of Clinical Pharmacy Position Statement (2004) Medication therapy management services definition and program criteria. Available at http://www.accp.com/docs/positions/positionStatements/pos032- 200407.pdf. Assessed 24 October 2011
3. Oliveira DR, Brummel AR, Miller DB (2007) Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm 16(3):185-195
4. Welch E, Delate T, Chester EA, Stubbings T (2009) Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries. Ann Pharmacother 43:603-610
5. http://www.un.org/esa/population/publications/worldageing19502050. Assessed 19 September 2011
6. Smith BD, Smith GL, Hortobagyi GN, Buchholz TA (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27(17):2758-2765
7. Population Reference Bureau (2010) Today's research on aging. July. No. 20. http://www.prb.org/pdf10/TodaysResearchAging20.pdf. Assessed 16 September 2011
8. http://www.mcys.gov.sg/successful-ageing/Report.html. Accessed 22 November 2009
9. Hajjar ER, Cafiero AC, Hanlon JT (2007) Polypharmacy in elderly patients. Am J Geriatr Pharmacother 5(4):345-351
10. Terret C (2005) Geriatric oncology - a challenge for the future. Eur Oncol Rev 24-26
11. Wedding U, Pientka L, Hoffken K (2007) Quality of life in elderly patients with cancer: a short review. Eur J Cancer 43:2203
12. http://www.moh.gov.sg/mohcorp/statistics.aspx?id=5526. Assessed 22 November 2009
13. Extermann M, Hurria A (2007) Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 25(14):1824-1831
14. Poon D (2008) Challenges in the practice of geriatric oncology in a national comprehensive cancer centre in Asia. Asia-Pac Oncol Haematol 1:67-68
15. American Society of Hospital Pharmacists (1993) ASHP statement on pharmaceutical care. Am J Hosp Pharm 50:1720-1723
16. Hanlon JT, Lindblad CIL, Hajjar ER, McCarthy TC (2003) Update on drug-related problems in the elderly. Am J Geriatr Pharmacother 1(1):38-43
17. Goldberg RM, Tabah-Fisch I, Bleiberg H et al (2006) Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly cancer patients with colorectal cancer. J Clin Oncol 24(25):4085-4091
18. Litchman SM, Hollis D, Antonius A et al (2006) Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: cancer and leukemia group B (CALGB 9762). J Clin Oncol 24(12):1846-1851
19. Wedding U, Honecker F, Bokemeyer C, Pientka L, Hoffken K (2007) Tolerance to chemotherapy in elderly patients with cancer. Cancer Control 14(1):44-56
20. Litchman SM, Buchholtz M, Marino J et al (1992) Use of cisplatin for elderly patients. Age Ageing 21:202-204
21. Smorenburg CH, ten Tije AJ, Bontenbal M et al (2003) Altered clearance of unbound paclitaxel in elderly patients with metastatic breast cancer. Eur J Cancer 39:196-202
22. Albert J, Ten T, Verweij J, Carducci MA et al (2005) Prospective evaluation of the pharmacokinetics and toxicity profile of docetaxel in the elderly. J Clin Oncol 23(6):1070-1077
23. Hurria A, Togawa K, Mohile SG et al (2011) Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 29(25):3457-3465
24. Extermann M, Boler I, Reich R et al (2010) The Chemotherapy Risk Assessment Scale for High-age patients (CRASH) score: design and validation. J Clin Oncol 28:15s, suppl; abstract 9000
25. Rhoads M, Thai A (2003) Physician acceptance rate of pharmacist recommendations to reduce use of potentially inappropriate medications in the assisted living setting. Consult Pharm 18(3):241-247
26. Von Muenster SJ, Carter BL, Weber CA, Ernst ME, Milchak JL, Steffensmeier JJ, Xu Y (2008) Description of pharmacist interventions during physician-pharmacist co-management of hypertension. Pharm World Sci 30(1):128-135
27. Doucette WR, McDonough RP, Klepser D, McCarthy R (2005) Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther 27(7):1104-1111
28. McCollum M, Nuffer W, Ellis SL, Turner CJ (2009) Physician acceptance of pharmacotherapy recommendations made by pharmacy students in a rural pharmacy-based diabetes care and education clinic. Am J Pharm Educ 73(2):24
29. Lundquist LM, Moye PM (2009) Resident physicians' acceptance of pharmacy students' pharmacotherapy recommendations during an ambulatory care advanced pharmacy practice experience. Am J Pharm Educ 73(8):145
30. Wilson S, Wahler R, Brown J, Doloresco F, Monte SV (2011) Impact of pharmacist intervention on clinical outcomes in the palliative care setting. Am J Hosp Palliat Med 28(5):316-320
31. Chumney EC, Robinson LC (2006) The effects of pharmacist interventions on patients with polypharmacy. Pharm Pract 4(3):103-109
32. Shah S, Dowell J, Greene S et al (2006) Evaluation of clinical pharmacy services in a haematology/oncology outpatient setting. Ann Pharmacother 40:1527-1533
33. Kjeldsen LJ, Jensen TB, Jensen JJ et al (2011) Physicians' evaluation of clinical pharmacy revealed increased focus on quality improvement and cost savings. Dan Med Bull 58(5):A4261
34. Alsoud NA, El-Hamamsy M, Zawahry HA, Al-Azizi M (2010) Effects of clinical pharmacist interventions on clinical outcomes in oncology patients. Res J Med Med Sci 5(2):133-141
35. Ganachari MS, Mahendra Kumar BJ, Shashikala CW, Fibin M (2010) Assessment of drug therapy interventions by clinical pharmacist in a tertiary care hospital. Indian J Pharm Pract 3(3):22-28
36. Knez L, Laaksonen R, Duggan C et al (2010) Evaluation of clinical interventions made by pharmacists in chemotherapy preparation. Radiol Oncol 44(4):249-256
37. Barnett MJ, Frank J, Wehring H et al (2009) Analysis of pharmacist provided medication therapy management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm 15(1):18-31
38. McMahan R (2008) Operationalizing MTM through the use of health information technology. J Manag Care Pharm 14(2 Suppl):S18-S21